317 reports of this reaction
1.3% of all DALTEPARIN SODIUM reports
#20 most reported adverse reaction
ABDOMINAL DISTENSION is the #20 most commonly reported adverse reaction for DALTEPARIN SODIUM, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 317 FDA adverse event reports linking DALTEPARIN SODIUM to ABDOMINAL DISTENSION. This represents approximately 1.3% of all 23,703 adverse event reports for this drug.
Patients taking DALTEPARIN SODIUM who experience abdominal distension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABDOMINAL DISTENSION is a less commonly reported adverse event for DALTEPARIN SODIUM, but still significant enough to appear in the safety profile.
In addition to abdominal distension, the following adverse reactions have been reported for DALTEPARIN SODIUM:
The following drugs have also been linked to abdominal distension in FDA adverse event reports:
ABDOMINAL DISTENSION has been reported as an adverse event in 317 FDA reports for DALTEPARIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABDOMINAL DISTENSION accounts for approximately 1.3% of all adverse event reports for DALTEPARIN SODIUM, making it a notable side effect.
If you experience abdominal distension while taking DALTEPARIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.